Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Study of Xcellerated T CellsTM With or Without Prior Fludarabine Therapy in Patients With Multiple Myeloma

NCT00078065 is registered in ClinicalTrials.gov with Xcyte Therapies as lead sponsor.

NCT NCT00078065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00078065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Study of Xcellerated T CellsTM With or Without Prior Fludarabine Therapy in Patients With Multiple Myeloma
Lead sponsor
Xcyte Therapies
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2003
Completion date
June 30, 2004
Enrollment
30
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma